Metformin Improves Colorectal Cancer Survival in Veterans

by U.S. Medicine

February 14, 2017

BOSTON—Metformin has been associated with improved colorectal cancer survival (CRC), but investigations have been limited by small numbers of patients and confounding by diabetic severity, according to a new study.

An article in the journal Cancer Epidemiology, Biomarker & Prevention reported research examining the association between metformin use and overall survival (OS) in patients with diabetes and CRC in a large population of U.S. veterans, while adjusting for measures of diabetic severity.1

To do that, the study team from Tufts Medical Center in Boston and the Durham, NC, VAMC identified patients diagnosed with CRC from January 2001 to December 2008 from the VA’s Central Cancer Registry. The researchers sought to determine how overall survival was influenced by diabetes and use of blood sugar-lowering medications.

Used in the study were records on 16,355 nondiabetic patients, 2,038 diabetic patients on metformin, 2,136 diabetic patients on medications other than metformin and 823 diabetic patients who were on no anti-diabetic medications.

Results indicate that diabetic patients had a significantly worse OS than nondiabetic patients, but metformin users had only a 10% increase in death, as compared to 22% for users of other anti-diabetic medications.

Among CRC patients with diabetes, metformin users had a 13% improved OS vs. patients taking other anti-diabetic medications, while diabetic patients not on any anti-diabetic medications did not differ with respect to OS.

“Among diabetics with CRC, metformin use is associated with improved survival, despite adjustments for diabetes severity and other risk factors,” according to study authors, who add that their results “lend further support to the conduct of randomized studies of possible anti-cancer effects of metformin among patients with CRC.”

  1. Paulus JK, Williams CD, Cossor FI, Kelley MJ, Martell RE. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1418-1425. PubMed PMID: 27496094; PubMed CentralPMCID: PMC5050110.

Comments are closed here.

Related Articles

Senate VA Committee Chair Vows to Pass ‘Blue Water’ Navy Benefits

Senate Committee on Veterans' Affairs Chairman Sen. Johnny Isakson (R-GA) vowed that addressing benefits for Blue Water Navy Veterans “is no longer going to be a question,” but that “how we do it is the only question.”

Suicide Rates Jump Up for Younger Veterans in Recent Years

Rates of suicide among younger veterans (ages 18-34) “increased substantially in recent years,” climbing from 40.4 suicide deaths per 100,000 population in 2015 to 45 suicide deaths per 100,000 population in 2016, according to a new report.

U.S. Medicine Recommends

More From department of veterans affairs

Department of Veterans Affairs (VA)

Senate VA Committee Chair Vows to Pass 'Blue Water' Navy Benefits

Senate Committee on Veterans' Affairs Chairman Sen. Johnny Isakson (R-GA) vowed that addressing benefits for Blue Water Navy Veterans “is no longer going to be a question,” but that “how we do it is the only question.”

Department of Veterans Affairs (VA)

VHA Makes Progress in Improving Safety of Opioid Prescribing

VHA medical facilities should ensure that its providers are following three key opioid risk mitigation strategies, including conducting urine drug screening, a recent report recommended.

Department of Veterans Affairs (VA)

VA faces healthcare staffing shortages, barriers to hiring facility leaders

A facility-specific survey found that 138 of 140 VA facilities reported shortages of medical officers, with psychiatry and primary care positions being the most frequently listed.

Department of Veterans Affairs (VA)

Veteran nephrologist labors to improve ESRD treatment at VA

When Terrence O’Neil, MD, retired as chief of nephrology at the James H. Quillen VAMC in Johnson City in December 2016, he left in his wake decades of work treating kidney disease—nearly 35 years in the Air Force and DoD, plus 11 more at VA.

Department of Veterans Affairs (VA)

Committee approves bill to provide agent orange benefits to ‘blue water’ vets

A long sought-after bill that would make it easier for Blue Water Navy veterans to receive Agent Orange benefits has been passed by a key House of Representatives committee.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up